• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION FREESTYLE AORTIC ROOT BIOPROSTHESIS; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION FREESTYLE AORTIC ROOT BIOPROSTHESIS; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 995
Device Problem Insufficient Information (3190)
Patient Problems Aortic Regurgitation (1716); Arrhythmia (1721); Endocarditis (1834); Transient Ischemic Attack (2109); Low Cardiac Output (2501); Blood Loss (2597); Thromboembolism (2654)
Event Date 06/28/2003
Event Type  Injury  
Manufacturer Narrative
Citation: melina g et al.Mid-term pattern of survival, hemodynamic performance and rate of complications after medtronic freestyle versus homograft full aortic root replacement: results from a prospective randomized trial.J heart valve dis.2004 nov;13(6):972-5; discussion 975-6.Presented at the second biennial meeting of the society for heart valve disease, 28th june-1st july 2003, palais des congrès, paris, france.Doi: not available ¿ literature pdf attached.Earliest date of publish used for event date in b3.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.Additional patient code(s): c50470, c50641, c50781, c50861.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding a comparison of the mid-term outcomes in patients who underwent aortic valve replacement with a freestyle bioprosthesis or a homograft.All data were collected from a single center.The study population included 147 patients and was predominantly male with a mean age of 66 years.Of those, 80 were implanted with medtronic freestyle bioprosthetic valves.No serial numbers were provided.Among all freestyle patients, the early mortality and late survival rates were 9.1% and 83%, respectively.No other details were reported.Based on the available information, medtronic product was not directly associated with the deaths.Among all freestyle patients, adverse events included: bleeding that required reoperation, mild aortic regurgitation, transient ischemic attack, thromboembolism, endocarditis, low cardiac output that required medication or intra-aortic balloon pump use, and post-operative atrial or ventricular arrhythmias.Based on the available information, medtronic product was associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE AORTIC ROOT BIOPROSTHESIS
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key9512691
MDR Text Key185072992
Report Number2025587-2019-03874
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P970031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 12/23/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number995
Device Catalogue Number995
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/03/2019
Initial Date FDA Received12/23/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
-
-